Bavarian Nordic A/S (BVNRY)
11.28
+0.23
(+2.12%)
USD |
OTCM |
Aug 25, 16:00
Bavarian Nordic Net Income (Quarterly) : 113.83M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 113.83M |
| March 31, 2026 | 2.655M |
| December 31, 2025 | -46.57M |
| September 30, 2025 | 171.12M |
| June 30, 2025 | 55.08M |
| March 31, 2025 | 30.86M |
| December 31, 2024 | 110.23M |
| September 30, 2024 | 10.38M |
| June 30, 2024 | 37.68M |
| March 31, 2024 | -16.66M |
| December 31, 2023 | 129.98M |
| September 30, 2023 | -49.72M |
| June 30, 2023 | 78.61M |
| March 31, 2023 | 54.25M |
| December 31, 2022 | 20.52M |
| September 30, 2022 | 1.638M |
| June 30, 2022 | -33.93M |
| March 31, 2022 | -41.00M |
| December 31, 2021 | -15.71M |
| September 30, 2021 | -12.91M |
| June 30, 2021 | -24.36M |
| March 31, 2021 | -21.19M |
| December 31, 2020 | -60.01M |
| September 30, 2020 | 4.137M |
| June 30, 2020 | 16.43M |
| Date | Value |
|---|---|
| March 31, 2020 | 75.87M |
| December 31, 2019 | -6.800M |
| September 30, 2019 | -14.78M |
| June 30, 2019 | -15.36M |
| March 31, 2019 | -15.16M |
| December 31, 2018 | -15.50M |
| September 30, 2018 | 4.949M |
| June 30, 2018 | -17.56M |
| March 31, 2018 | -30.11M |
| December 31, 2017 | -29.20M |
| September 30, 2017 | 51.43M |
| June 30, 2017 | 6.854M |
| March 31, 2017 | -0.8674M |
| December 31, 2016 | 12.65M |
| September 30, 2016 | 14.67M |
| June 30, 2016 | -3.913M |
| March 31, 2016 | -19.03M |
| December 31, 2015 | 0.3396M |
| September 30, 2015 | -7.392M |
| June 30, 2015 | 9.087M |
| March 31, 2015 | 6.851M |
| December 31, 2014 | 16.44M |
| September 30, 2014 | -3.254M |
| June 30, 2014 | -10.09M |
| March 31, 2014 | 0.2203M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Evaxion AS | -3.724M |
| Genmab A/S | 302.57M |
| Ascendis Pharma A/S | 240.65M |
| Zealand Pharma A/S | 609.41M |
| Agenus, Inc. | -0.567M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 315.94M |
| Total Expenses (Quarterly) | 202.11M |
| EPS Diluted (Quarterly) | 0.4995 |
| Enterprise Value | 2.230B |
| Gross Profit Margin (Quarterly) | 60.45% |
| Profit Margin (Quarterly) | 36.03% |
| Earnings Yield | 9.23% |
| Operating Earnings Yield | 6.09% |
| Normalized Earnings Yield | 8.913 |